NATURE OF OPERATIONS |
12 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| NATURE OF OPERATIONS | 1. NATURE OF OPERATIONS
Biotricity Inc. (formerly MetaSolutions, Inc.) (the “Company” or “Biotricity”) was incorporated under the laws of the State of Nevada on August 29, 2012. iMedical Innovations Inc. (“iMedical”) was incorporated on July 3, 2014 under the laws of the Province of Ontario, Canada and became a wholly-owned subsidiary of Biotricity through reverse take-over on February 2, 2016.
The Company and iMedical are engaged in the research, development and commercialization of technology-enabled healthcare solutions focused on remote patient monitoring, diagnostics and chronic disease management. The Company’s principal products include the Bioflux® platform, a mobile cardiac telemetry and remote cardiac monitoring solution designed to assist healthcare providers in the diagnosis and management of cardiac arrhythmias, and the Biocore® platform, a wearable remote monitoring solution that enables the collection, transmission and analysis of physiological data. The Company is focused on developing and commercializing an ecosystem of connected healthcare technologies that improve patient outcomes while providing healthcare providers with actionable clinical information.
To date, the Company’s efforts have been primarily devoted to research and development activities, product commercialization, expanding its customer base, and enhancing its remote monitoring technology platform and related services.
|